Adaptabodies: Retargeting a Predefined Monoclonal Antibody With Bispecific Nanobodies for Antibody Therapy
Sign Up to like & getrecommendations! Published in 2025 at "Biotechnology Journal"
DOI: 10.1002/biot.70089
Abstract: Monoclonal antibody (MoAb) therapy is a cornerstone in treating cancer, inflammatory diseases, and infections. However, the development of new monoclonal antibodies is labor‐intensive, costly, and species‐specific, limiting their accessibility in veterinary medicine and slowing innovation… read more here.
Keywords: monoclonal antibody; antibody; retargeting predefined; adaptabodies retargeting ... See more keywords